PET Imaging of Cannabinoid CB1 Receptors Using [18F]FMPEP-d2
The purpose of this protocol is to measure brain CB1 receptors in the hope to better understand how they work, so that one day we can understand how the CB1 receptors are involved in psychiatric, neurological, and behavioral disorders.
|Study Design:||Allocation: Non-Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Diagnostic
|Official Title:||Imaging of Cannabinoid CB1 Receptors Using [18F]FMPEP-d2|
- Efficacy of novel PET tracer for CB1 in brain imaging.
- Distribution and variance of CB1 receptors in the brain of healthy controls.
|Study Start Date:||January 2008|
|Study Completion Date:||October 2009|
|Primary Completion Date:||October 2009 (Final data collection date for primary outcome measure)|
Please refer to this study by its ClinicalTrials.gov identifier: NCT00598286
|United States, Maryland|
|National Institutes of Health Clinical Center, 9000 Rockville Pike|
|Bethesda, Maryland, United States, 20892|